• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

开发两种创新性的基于表现的猫骨关节炎客观测量方法:其可靠性以及对非罗考昔布镇痛治疗的反应性。

Development of Two Innovative Performance-Based Objective Measures in Feline Osteoarthritis: Their Reliability and Responsiveness to Firocoxib Analgesic Treatment.

机构信息

Groupe de Recherche en Pharmacologie Animale du Québec (GREPAQ), Department of Biomedical Sciences, Faculty of Veterinary Medicine, Université de Montréal, St.-Hyacinthe, QC J2S 2M2, Canada.

Osteoarthritis Research Unit, University of Montreal Hospital Research Center (CRCHUM), Montréal, QC H2X 0A9, Canada.

出版信息

Int J Mol Sci. 2022 Oct 4;23(19):11780. doi: 10.3390/ijms231911780.

DOI:10.3390/ijms231911780
PMID:36233085
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9569873/
Abstract

The metrological properties of two performance-based outcome measures of feline osteoarthritis (OA), namely Effort Path (Path) and Stairs Assay Compliance (Stairs), were tested. Cats naturally affected by OA (n = 32) were randomly distributed into four groups (A: 0.40, B: 0.25, C: 0.15, or D: 0.00 mg firocoxib/kg bodyweight) and assessed during baseline, treatment, and recovery periods. For Path, from an elevated walking platform, the cats landed on a pressure-sensitive mattress and jumped up onto a second elevated platform. Analysis included velocity, time to completion, peak vertical force (PVF), and vertical impulse. For Stairs, the number of steps and time to completion were recorded for 16 steps up and down in a 4 min period. Reliability was moderate to very good for Path and poor to good for Stairs. Different normalization methods are described in the manuscript. The placebo group remained stable within-time in Path, whereas treated cats trotted faster on the ramp (p < 0.0001), improved their PVF (p < 0.018) and completed the task quicker (p = 0.003). The percentage of cats completing the Stairs finish line was higher under treatment (p < 0.036), with huge effect size, the placebo group results being stable within-time. Both are promising performance-based outcome measures to better diagnose and manage feline OA pain.

摘要

两种猫骨关节炎(OA)基于表现的结果测量方法(Effort Path,Path 和 Stairs Assay Compliance,Stairs)的计量学特性进行了测试。患有 OA 的自然发病猫(n = 32)被随机分为四组(A:0.40、B:0.25、C:0.15 或 D:0.00 mg 非诺考昔/千克体重),并在基线、治疗和恢复期进行评估。对于 Path,猫从升高的行走平台上跳下,落在压力敏感床垫上,然后跳上第二个升高的平台。分析包括速度、完成时间、峰值垂直力(PVF)和垂直冲量。对于 Stairs,在 4 分钟内记录上下 16 步的步数和完成时间。Path 的可靠性为中等至很好,Stairs 的可靠性为差至好。文中描述了不同的归一化方法。安慰剂组在 Path 中保持稳定,而治疗猫在斜坡上跑得更快(p <0.0001),提高了他们的 PVF(p <0.018)并更快地完成任务(p = 0.003)。在治疗下,完成 Stairs 终点线的猫的比例更高(p <0.036),具有巨大的效果量,安慰剂组的结果在时间内保持稳定。这两种方法都是有前途的基于表现的结果测量方法,可更好地诊断和管理猫的 OA 疼痛。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d06/9569873/91bb038ab04e/ijms-23-11780-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d06/9569873/7d82bf956f1a/ijms-23-11780-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d06/9569873/16eef8c15a55/ijms-23-11780-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d06/9569873/bfb14582a5b8/ijms-23-11780-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d06/9569873/91bb038ab04e/ijms-23-11780-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d06/9569873/7d82bf956f1a/ijms-23-11780-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d06/9569873/16eef8c15a55/ijms-23-11780-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d06/9569873/bfb14582a5b8/ijms-23-11780-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d06/9569873/91bb038ab04e/ijms-23-11780-g004.jpg

相似文献

1
Development of Two Innovative Performance-Based Objective Measures in Feline Osteoarthritis: Their Reliability and Responsiveness to Firocoxib Analgesic Treatment.开发两种创新性的基于表现的猫骨关节炎客观测量方法:其可靠性以及对非罗考昔布镇痛治疗的反应性。
Int J Mol Sci. 2022 Oct 4;23(19):11780. doi: 10.3390/ijms231911780.
2
The effectiveness of marine based fatty acid compound (PCSO-524) and firocoxib in the treatment of canine osteoarthritis.海洋来源脂肪酸复合物(PCSO-524)和非甾体类抗炎药(firocoxib)治疗犬骨关节炎的效果。
BMC Vet Res. 2019 Oct 17;15(1):349. doi: 10.1186/s12917-019-2110-7.
3
Concurrent Validation of MI-CAT(V), a Clinical Metrology Instrument for Veterinarians Assessing Osteoarthritis Pain in Cats, through Testing for Firocoxib Analgesic Efficacy in a Prospective, Randomized, Controlled, and Blinded Study.通过在一项前瞻性、随机、对照和双盲研究中测试非甾体抗炎药(firocoxib)的镇痛效果,对MI-CAT(V)进行同步验证,MI-CAT(V)是一种用于兽医评估猫骨关节炎疼痛的临床计量仪器。
Animals (Basel). 2024 Feb 24;14(5):711. doi: 10.3390/ani14050711.
4
Analgesic efficacy of tramadol in cats with naturally occurring osteoarthritis.曲马多对自然发生骨关节炎猫的镇痛效果。
PLoS One. 2017 Apr 12;12(4):e0175565. doi: 10.1371/journal.pone.0175565. eCollection 2017.
5
Comparison of efficacy and safety of paste formulations of firocoxib and phenylbutazone in horses with naturally occurring osteoarthritis.氟罗昔布和保泰松膏剂对自然发生骨关节炎马匹的疗效和安全性比较。
J Am Vet Med Assoc. 2008 Jan 1;232(1):91-7. doi: 10.2460/javma.232.1.91.
6
Characterization of osteoarthritis in cats and meloxicam efficacy using objective chronic pain evaluation tools.猫骨关节炎的特征及美洛昔康的疗效:使用客观慢性疼痛评估工具。
Vet J. 2013 Jun;196(3):360-7. doi: 10.1016/j.tvjl.2013.01.009. Epub 2013 Feb 14.
7
Evaluation of oral administration of firocoxib for the management of musculoskeletal pain and lameness associated with osteoarthritis in horses.评估口服非甾体抗炎药氟罗昔康对治疗马骨关节炎相关的肌肉骨骼疼痛和跛行的效果。
Am J Vet Res. 2012 May;73(5):664-71. doi: 10.2460/ajvr.73.5.664.
8
Efficacy and safety of firocoxib in the management of canine osteoarthritis under field conditions.非甾体抗炎药氟罗昔布在野外条件下治疗犬骨关节炎的疗效与安全性
Vet Ther. 2006 Summer;7(2):127-40.
9
Clinical evaluation of firocoxib and carprofen for the treatment of dogs with osteoarthritis.非罗考昔和卡洛芬治疗犬骨关节炎的临床评价。
Vet Rec. 2006 Oct 21;159(17):547-51. doi: 10.1136/vr.159.17.547.
10
Analgesic efficacy of oral firocoxib in ovariohysterectomized cats.口服非罗考昔对卵巢子宫切除猫的镇痛效果。
J Vet Sci. 2017 Jun 30;18(2):175-182. doi: 10.4142/jvs.2017.18.2.175.

引用本文的文献

1
Declawing in Cat is associated with neuroplastic sensitization and long-term painful afflictions.给猫去爪与神经可塑性致敏和长期疼痛折磨有关。
Sci Rep. 2025 Aug 17;15(1):30038. doi: 10.1038/s41598-025-16288-8.
2
Osteoarthritis in cats: what we know, and mostly, what we don't know. . . yet.猫的骨关节炎:我们所知道的,以及大多数情况下,我们还不知道的…… 目前。
J Feline Med Surg. 2025 Jul;27(7):1098612X251347999. doi: 10.1177/1098612X251347999. Epub 2025 Jul 20.
3
2024 ISFM and AAFP consensus guidelines on the long-term use of NSAIDs in cats.

本文引用的文献

1
Relationship between Ground Reaction Forces and Morpho- Metric Measures in Two Different Canine Phenotypes Using Regression Analysis.使用回归分析研究两种不同犬类表型中地面反作用力与形态测量指标之间的关系。
Vet Sci. 2022 Jun 28;9(7):325. doi: 10.3390/vetsci9070325.
2
Best practices for measuring and reporting ground reaction forces in dogs.测量和报告犬类地面反力的最佳实践。
Vet Surg. 2022 Apr;51(3):385-396. doi: 10.1111/vsu.13772. Epub 2022 Jan 26.
3
Robenacoxib shows efficacy for the treatment of chronic degenerative joint disease-associated pain in cats: a randomized and blinded pilot clinical trial.
2024 年 ISFM 和 AAFP 关于猫科动物 NSAIDs 长期使用的共识指南。
J Feline Med Surg. 2024 Apr;26(4):1098612X241241951. doi: 10.1177/1098612X241241951.
4
Concurrent Validation of MI-CAT(V), a Clinical Metrology Instrument for Veterinarians Assessing Osteoarthritis Pain in Cats, through Testing for Firocoxib Analgesic Efficacy in a Prospective, Randomized, Controlled, and Blinded Study.通过在一项前瞻性、随机、对照和双盲研究中测试非甾体抗炎药(firocoxib)的镇痛效果,对MI-CAT(V)进行同步验证,MI-CAT(V)是一种用于兽医评估猫骨关节炎疼痛的临床计量仪器。
Animals (Basel). 2024 Feb 24;14(5):711. doi: 10.3390/ani14050711.
5
Research of Pathogenesis and Novel Therapeutics in Arthritis 3.0.关节炎 3.0 的发病机制与新型治疗方法研究。
Int J Mol Sci. 2023 Jun 15;24(12):10166. doi: 10.3390/ijms241210166.
罗非昔布治疗猫慢性退行性关节疾病相关疼痛的疗效:一项随机和盲法的初步临床试验。
Sci Rep. 2021 Apr 8;11(1):7721. doi: 10.1038/s41598-021-87023-2.
4
Owner evaluation of quality of life and mobility in osteoarthritic cats treated with amantadine or placebo.骨关节炎猫用金刚烷胺或安慰剂治疗后的主人对生活质量和活动能力的评估。
J Feline Med Surg. 2021 Jun;23(6):568-574. doi: 10.1177/1098612X20967639. Epub 2020 Oct 28.
5
Utility of a novel activity monitor assessing physical activities and sleep quality in cats.新型活动监测器在评估猫的身体活动和睡眠质量方面的效用。
PLoS One. 2020 Jul 31;15(7):e0236795. doi: 10.1371/journal.pone.0236795. eCollection 2020.
6
Quantitative sensory testing in feline osteoarthritic pain - a systematic review and meta-analysis.猫骨关节炎疼痛的定量感觉测试 - 系统评价和荟萃分析。
Osteoarthritis Cartilage. 2020 Jul;28(7):885-896. doi: 10.1016/j.joca.2020.04.006. Epub 2020 Apr 29.
7
Novel use of an activity monitor to model jumping behaviors in cats.
Am J Vet Res. 2020 Apr;81(4):334-343. doi: 10.2460/ajvr.81.4.334.
8
Development of a checklist for the detection of degenerative joint disease-associated pain in cats.猫退行性关节病相关疼痛检测检查表的制定。
J Feline Med Surg. 2020 Dec;22(12):1137-1147. doi: 10.1177/1098612X20907424. Epub 2020 Mar 3.
9
Kinetic analysis of felines landing from different heights.猫从不同高度着陆的动力学分析。
PeerJ. 2019 Nov 12;7:e8007. doi: 10.7717/peerj.8007. eCollection 2019.
10
The effectiveness of marine based fatty acid compound (PCSO-524) and firocoxib in the treatment of canine osteoarthritis.海洋来源脂肪酸复合物(PCSO-524)和非甾体类抗炎药(firocoxib)治疗犬骨关节炎的效果。
BMC Vet Res. 2019 Oct 17;15(1):349. doi: 10.1186/s12917-019-2110-7.